Beryllium Discovery has become a fully owned subsidiary of UK-based pharmaceutical company UCB Pharma, with the latter acquiring the remaining stake in the former.
"China Meheco has announced its plans to acquire 54% stake in a pharmaceutical company based in the Hainan province."
The target company is a drug discovery contract research organisation.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The acquirer company expects the acquisition to help grow its pipeline.
China Meheco has announced its plans to acquire 54% stake in a pharmaceutical company based in the Hainan province.
The purchase consideration for the transaction is expected to be CNY286.2m ($42.05m).
GlobalData Strategic Intelligence
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
